Ophthalmology Department, Hospital Regional of Malaga, Malaga, Spain.
Instituto de Investigación Biomédica de Málaga; Laboratorio de Biologia Molecular del Cáncer, Malaga, Spain.
Indian J Ophthalmol. 2020 Aug;68(8):1556-1562. doi: 10.4103/ijo.IJO_1865_19.
To characterize anatomical and functional changes in the ocular surface after hematopoietic stem cell transplantation.
Three groups of patients were included in the study. Group 1: patients who had undergone allogeneic hematopoietic stem cell transplantation (HSCT) (n = 26). Group 2: patients who developed chronic graft versus host disease (GvHD) after HSCT (n = 14). Group 3: healthy subjects (n = 20). A complete ophthalmological examination was undertaken in all subjects, including Schirmer's test, TBUT (break-up-time) test, Oxford scale, OSDI test, corneal tomography, and conjunctival CD8+ lymphocyte detection.
In Branch 1 (comparative analysis before and after HSCT in Group 1), statistically significant differences were found in the following variables: best-corrected visual acuity (BCVA) OD (P = 0.08), OSDI test (P = 0.003), TBUT OU (OD P= 0, OS P= 0.0003), Oxford test OU (OD P= 0.01, OS P= 0.0049), and CD8+ lymphocytes OU (OD P= 0.003, OS P= 0.01). In Branch 2 (comparative analysis between Group 2 and 3), the variables with statistically significant differences (P < 0.001) in OU were: BCVA, OSDI test, Schirmer's test OU, TBUT test, Oxford test, and CD8+ lymphocytes. Finally, in Branch 3 (comparative analysis between Group 1 after HSCT and Group 2), statistically significant differences (P < 0.001) were found OU: in OSDI test, Schirmer's test, and Oxford test OU; and with P < 0.005 in TBUT test OU.
In our study, statistically significant changes were observed in the OSDI test, TBUT test, Oxford Scale, and the detection of CD8+ lymphocytes in patients who underwent HSCT. Differences were more significant in those patients who had developed GvHD after HSCT compared to those without GvHD.
描述造血干细胞移植后眼表的解剖和功能变化。
本研究纳入了三组患者。第 1 组:接受异基因造血干细胞移植(HSCT)的患者(n=26)。第 2 组:HSCT 后发生慢性移植物抗宿主病(GvHD)的患者(n=14)。第 3 组:健康受试者(n=20)。所有受试者均接受全面的眼科检查,包括 Schirmer 测试、泪膜破裂时间(TBUT)测试、Oxford 量表、OSDI 测试、角膜断层扫描和结膜 CD8+淋巴细胞检测。
在第 1 分支(第 1 组 HSCT 前后的对比分析)中,以下变量存在统计学显著差异:最佳矫正视力(BCVA)OD(P=0.08)、OSDI 测试(P=0.003)、TBUT OU(OD P=0,OS P=0.0003)、Oxford 测试 OU(OD P=0.01,OS P=0.0049)和 CD8+淋巴细胞 OU(OD P=0.003,OS P=0.01)。在第 2 分支(第 2 组与第 3 组的对比分析)中,OU 变量具有统计学显著差异(P<0.001):BCVA、OSDI 测试、Schirmer 测试 OU、TBUT 测试、Oxford 测试和 CD8+淋巴细胞。最后,在第 3 分支(HSCT 后第 1 组与第 2 组的对比分析)中,OU 变量存在统计学显著差异(P<0.001):OSDI 测试、Schirmer 测试和 Oxford 测试 OU;TBUT 测试 OU 存在统计学显著差异(P<0.005)。
在我们的研究中,接受 HSCT 的患者的 OSDI 测试、TBUT 测试、Oxford 量表和 CD8+淋巴细胞检测结果存在统计学显著变化。与未发生 GvHD 的患者相比,HSCT 后发生 GvHD 的患者差异更为显著。